{
  "DOI": "10.1186/s40246-018-0145-7",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-018-0145-7",
  "alternative-id": [
    "145"
  ],
  "article-number": "14",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "14 December 2017"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "28 February 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "9 March 2018"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "All procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964, as revised in 2000 [CitationRef removed]. Informed written consent was obtained from all patients. All patients consented to the publication of their data. The institutional Ethic Committee of the Charité consented to the procedures and the publication of the data (EA2/089/15)."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Ursula Plöckinger was the recipient of an unrestricted grant by Genzyme, Germany, received speaker honorarium from Sanofi Genzyme, Germany; BioMarin Germany, and a research grant from Pfizer, Germany. Nikolaus Tiling has received a speaker honorarium from Shire, Germany and Sanofi Genzyme, Germany. V. Prasad, A. Poellinger and A. Ziagaki have nothing to declare."
    },
    {
      "group": {
        "label": "Publisher’s Note",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-0654-5066",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Plöckinger",
      "given": "U.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Prasad",
      "given": "V.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ziagaki",
      "given": "A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tiling",
      "given": "N.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Poellinger",
      "given": "A.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2018,
        3,
        9
      ]
    ],
    "date-time": "2018-03-09T12:52:53Z",
    "timestamp": 1520599973000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        3,
        9
      ]
    ],
    "date-time": "2019-03-09T00:12:14Z",
    "timestamp": 1552090334000
  },
  "funder": [
    {
      "DOI": "10.13039/100013995",
      "doi-asserted-by": "crossref",
      "name": "Sanofi Genzyme"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2022,
        3,
        29
      ]
    ],
    "date-time": "2022-03-29T19:07:41Z",
    "timestamp": 1648580861314
  },
  "is-referenced-by-count": 1,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2018,
        3,
        9
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2018,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2018,
            3,
            9
          ]
        ],
        "date-time": "2018-03-09T00:00:00Z",
        "timestamp": 1520553600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-018-0145-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/s40246-018-0145-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-018-0145-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2018,
        3,
        9
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2018,
        3,
        9
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1007/s00115-013-3947-9",
      "author": "A Schuller",
      "doi-asserted-by": "publisher",
      "first-page": "1467",
      "journal-title": "Nervenarzt",
      "key": "145_CR1",
      "unstructured": "Schuller A, Kornblum C, Deschauer M, Vorgerd M, Schrank B, Mengel E, et al. Diagnosis and therapy of late onset Pompe disease. Nervenarzt. 2013;84:1467–72.",
      "volume": "84",
      "year": "2013"
    },
    {
      "author": "JW Teener",
      "first-page": "506",
      "journal-title": "Semin Neurol",
      "key": "145_CR2",
      "unstructured": "Teener JW. Late-onset Pompe’s disease. Semin Neurol. 2012;32:506–11.",
      "volume": "32",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10545-012-9451-8",
      "author": "C Regnery",
      "doi-asserted-by": "publisher",
      "first-page": "837",
      "journal-title": "J Inherit Metab Dis",
      "key": "145_CR3",
      "unstructured": "Regnery C, Kornblum C, Hanisch F, Vielhaber S, Strigl-Pill N, Grunert B, et al. 36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy. J Inherit Metab Dis. 2012;35:837–45.",
      "volume": "35",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10545-011-9388-3",
      "author": "CI van Capelle",
      "doi-asserted-by": "publisher",
      "first-page": "317",
      "journal-title": "J Inherit Metab Dis",
      "key": "145_CR4",
      "unstructured": "van Capelle CI, van der Beek NA, de Vries JM, van Doorn PA, Duivenvoorden HJ, Leshner RT, et al. The quick motor function test: a new tool to rate clinical severity and motor function in Pompe patients. J Inherit Metab Dis. 2012;35:317–23.",
      "volume": "35",
      "year": "2012"
    },
    {
      "DOI": "10.1183/09031936.00194909",
      "author": "C Casanova",
      "doi-asserted-by": "publisher",
      "first-page": "150",
      "journal-title": "Eur Respir J",
      "key": "145_CR5",
      "unstructured": "Casanova C, Celli BR, Barria P, Casas A, Cote C, de Torres JP, et al. The 6-min walk distance in healthy subjects: reference standards from seven countries. Eur Respir J. 2011;37:150–6.",
      "volume": "37",
      "year": "2011"
    },
    {
      "DOI": "10.1164/ajrccm.166.1.at1102",
      "author": "Laboratories ATSCoPSfCPF",
      "doi-asserted-by": "publisher",
      "first-page": "111",
      "journal-title": "Am J Respir Crit Care Med",
      "key": "145_CR6",
      "unstructured": "Laboratories ATSCoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–7.",
      "volume": "166",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.ymgme.2014.02.015",
      "author": "CS Andreassen",
      "doi-asserted-by": "publisher",
      "first-page": "40",
      "journal-title": "Mol Genet Metab",
      "key": "145_CR7",
      "unstructured": "Andreassen CS, Schlutter JM, Vissing J, Andersen H. Effect of enzyme replacement therapy on isokinetic strength for all major muscle groups in four patients with Pompe disease-a long-term follow-up. Mol Genet Metab. 2014;112:40–3.",
      "volume": "112",
      "year": "2014"
    },
    {
      "DOI": "10.1002/ajmg.c.31320",
      "author": "SP Young",
      "doi-asserted-by": "publisher",
      "first-page": "50",
      "journal-title": "Am J Med Genet Part C Sem Med Genet",
      "key": "145_CR8",
      "unstructured": "Young SP, Piraud M, Goldstein JL, Zhang H, Rehder C, Laforet P, et al. Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques. Am J Med Genet Part C Sem Med Genet. 2012;160c:50–8.",
      "volume": "160c",
      "year": "2012"
    },
    {
      "DOI": "10.1371/journal.pone.0163493",
      "author": "S Figueroa-Bonaparte",
      "doi-asserted-by": "publisher",
      "first-page": "e0163493",
      "journal-title": "PLoS One",
      "key": "145_CR9",
      "unstructured": "Figueroa-Bonaparte S, Segovia S, Llauger J, Belmonte I, Pedrosa I, Alejaldre A, et al. Muscle MRI findings in childhood/adult onset Pompe disease correlate with muscle function. PLoS One. 2016;11:e0163493. \n                    https://doi.org/10.1371/journal.pone.0163493\n                    \n                  .",
      "volume": "11",
      "year": "2016"
    },
    {
      "DOI": "10.1002/mus.24437",
      "author": "JJ Horvath",
      "doi-asserted-by": "publisher",
      "first-page": "722",
      "journal-title": "Muscle Nerve",
      "key": "145_CR10",
      "unstructured": "Horvath JJ, Austin SL, Case LE, Greene KB, Jones HN, Soher BJ, et al. Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease. Muscle Nerve. 2015;51:722–30.",
      "volume": "51",
      "year": "2015"
    },
    {
      "DOI": "10.1002/mus.24936",
      "author": "A Pichiecchio",
      "doi-asserted-by": "publisher",
      "first-page": "326",
      "journal-title": "Muscle Nerve",
      "key": "145_CR11",
      "unstructured": "Pichiecchio A, Berardinelli A, Moggio M, Rossi M, Balottin U, Comi GP, et al. Asymptomatic Pompe disease: can muscle magnetic resonance imaging facilitate diagnosis? Muscle Nerve. 2016;53:326–7.",
      "volume": "53",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s10545-015-9825-9",
      "author": "PG Carlier",
      "doi-asserted-by": "publisher",
      "first-page": "565",
      "journal-title": "J Inherit Metab Dis",
      "key": "145_CR12",
      "unstructured": "Carlier PG, Azzabou N, de Sousa PL, Hicks A, Boisserie JM, Amadon A, et al. Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients. J Inherit Metab Dis. 2015;38:565–72.",
      "volume": "38",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ymgme.2016.05.013",
      "author": "A van der Ploeg",
      "doi-asserted-by": "publisher",
      "first-page": "115",
      "journal-title": "Mol Genet Metab",
      "key": "145_CR13",
      "unstructured": "van der Ploeg A, Carlier PG, Carlier RY, Kissel JT, Schoser B, Wenninger S, et al. Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: the EMBASSY study. Mol Genet Metab. 2016;119:115–23.",
      "volume": "119",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.nmd.2012.05.011",
      "author": "A Alejaldre",
      "doi-asserted-by": "publisher",
      "first-page": "S148",
      "issue": "Suppl 2",
      "journal-title": "Neuromuscul Disord",
      "key": "145_CR14",
      "unstructured": "Alejaldre A, Diaz-Manera J, Ravaglia S, Tibaldi EC, D'Amore F, Moris G, et al. Trunk muscle involvement in late-onset Pompe disease: study of thirty patients. Neuromuscul Disord. 2012;22(Suppl 2):S148–54.",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.nmd.2011.06.748",
      "author": "RY Carlier",
      "doi-asserted-by": "publisher",
      "first-page": "791",
      "journal-title": "Neuromuscul Disord",
      "key": "145_CR15",
      "unstructured": "Carlier RY, Laforet P, Wary C, Mompoint D, Laloui K, Pellegrini N, et al. Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: involvement patterns. Neuromuscul Disord. 2011;21:791–9.",
      "volume": "21",
      "year": "2011"
    },
    {
      "author": "KM Gruhn",
      "first-page": "58",
      "journal-title": "MGM Rep",
      "key": "145_CR16",
      "unstructured": "Gruhn KM, Heyer CM, Guttsches AK, Rehmann R, Nicolas V, Schmidt-Wilcke T, et al. Muscle imaging data in late-onset Pompe disease reveal a correlation between the pre-existing degree of lipomatous muscle alterations and the efficacy of long-term enzyme replacement therapy. MGM Rep. 2015;3:58–64.",
      "volume": "3",
      "year": "2015"
    },
    {
      "DOI": "10.2214/AJR.08.1764",
      "author": "M Schulze",
      "doi-asserted-by": "publisher",
      "first-page": "1708",
      "journal-title": "AJR",
      "key": "145_CR17",
      "unstructured": "Schulze M, Kotter I, Ernemann U, Fenchel M, Tzaribatchev N, Claussen CD, et al. MRI findings in inflammatory muscle diseases and their noninflammatory mimics. AJR. 2009;192:1708–16.",
      "volume": "192",
      "year": "2009"
    },
    {
      "DOI": "10.1148/radiol.13131669",
      "author": "T Kanda",
      "doi-asserted-by": "publisher",
      "first-page": "834",
      "journal-title": "Radiology",
      "key": "145_CR18",
      "unstructured": "Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology. 2014;270:834–41.",
      "volume": "270",
      "year": "2014"
    },
    {
      "DOI": "10.1007/8904_2015_473",
      "author": "A Rozdzynska-Swiatkowska",
      "doi-asserted-by": "publisher",
      "first-page": "45",
      "journal-title": "JIMD Rep",
      "key": "145_CR19",
      "unstructured": "Rozdzynska-Swiatkowska A, Jurkiewicz E, Tylki-Szymanska A. Bioimpedance analysis as a method to evaluate the proportion of fatty and muscle tissues in progressive myopathy in Pompe disease. JIMD Rep. 2016;26:45–51.",
      "volume": "26",
      "year": "2016"
    },
    {
      "author": "M Orth",
      "first-page": "49",
      "journal-title": "NMD",
      "key": "145_CR20",
      "unstructured": "Orth M, Mundegar RR. Effect of acid maltase deficiency on the endosomal/lysosomal system and glucose transporter 4. NMD. 2003;13:49–54.",
      "volume": "13",
      "year": "2003"
    },
    {
      "DOI": "10.1152/ajpendo.00066.2010",
      "author": "HP Lauritzen",
      "doi-asserted-by": "publisher",
      "first-page": "E169",
      "journal-title": "Am J Physiol Endocrinol Metab",
      "key": "145_CR21",
      "unstructured": "Lauritzen HP, Schertzer JD. Measuring GLUT4 translocation in mature muscle fibers. Am J Physiol Endocrinol Metab. 2010;299:E169–79.",
      "volume": "299",
      "year": "2010"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-13-2768",
      "author": "TH Witney",
      "doi-asserted-by": "publisher",
      "first-page": "1319",
      "journal-title": "Cancer Res",
      "key": "145_CR22",
      "unstructured": "Witney TH, Carroll L, Alam IS, Chandrashekran A, Nguyen QD, Sala R, et al. A novel radiotracer to image glycogen metabolism in tumors by positron emission tomography. Cancer Res. 2014;74:1319–28.",
      "volume": "74",
      "year": "2014"
    },
    {
      "DOI": "10.1001/jama.2013.281053",
      "author": "Association WM",
      "doi-asserted-by": "publisher",
      "first-page": "2191",
      "journal-title": "JAMA",
      "key": "145_CR23",
      "unstructured": "Association WM. World medical association declaration of Helsinki ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–4.",
      "volume": "310",
      "year": "2013"
    }
  ],
  "reference-count": 23,
  "references-count": 23,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-018-0145-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "12"
}